Ratan Capital Management Portfolio holdings
Top Buys
| 1 |
AGN
Allergan Inc
AGN
|
+$79.3M |
| 2 |
SLCA
U.S. SILICA HOLDINGS, INC.
SLCA
|
+$38M |
| 3 |
Charter Communications
CHTR
|
+$38M |
| 4 |
DISH
DISH Network Corp.
DISH
|
+$33.6M |
| 5 |
FDO
FAMILY DOLLAR STORES
FDO
|
+$30.1M |
Top Sells
| 1 |
ZQK
QUICKSILVER,INC.
ZQK
|
+$11.5M |
| 2 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$9.94M |
| 3 |
FRX
FOREST LABORATORIES INC
FRX
|
+$9.33M |
| 4 |
CIR
CIRCOR International, Inc
CIR
|
+$6.71M |
| 5 |
AVHI
A V Homes, Inc.
AVHI
|
+$5.52M |
Sector Composition
| 1 | Healthcare | 46.62% |
| 2 | Consumer Staples | 16.8% |
| 3 | Communication Services | 13.7% |
| 4 | Materials | 6.34% |
| 5 | Industrials | 4.71% |
Similar funds
Ratan Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Ratan Capital Management held 23 positions worth $705M, up 72% from $410M the previous quarter. Its ten largest holdings account for 82% of the portfolio.
Ratan Capital Management deployed $263M of net new capital in Q2 2014, opening 8 new positions and adding to 4 existing holdings. Its largest new stake was Allergan Inc: 509,192 shares worth $86.2M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 55% a quarter earlier, followed by Consumer Staples and Communication Services.
On the sell side, the largest reduction was FOREST LABORATORIES INC, an estimated $9.33M trimmed.
- Ratan Capital Management's largest Q2 2014 buy was Allergan Inc: 509,192 shares worth $86.2M.
- Ratan Capital Management added most to Charter Communications in Q2 2014, an estimated $38M increase.
- Ratan Capital Management's biggest Q2 2014 reduction was FOREST LABORATORIES INC, cutting an estimated $9.33M.
- Ratan Capital Management fully exited QUICKSILVER,INC. in Q2 2014, selling an estimated $11.5M.
- Ratan Capital Management's ten largest holdings make up 82% of its $705M portfolio in Q2 2014.
- Ratan Capital Management opened 8 new positions and closed 4 in Q2 2014.
- Ratan Capital Management's portfolio value rose 72% quarter-over-quarter to $705M.
Based on Ratan Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.